Athens Medical Centre (STU:ACS) EBIT: €8.3 Mil (TTM As of Dec. 2025)


STU:ACS Athens Medical Centre SA STU:ACS
60 GF Score
Price €1.59
GF Value €1.93
! 8 Warning Signs
View Full Analysis

What is Athens Medical Centre EBIT?

Athens Medical Centre STU:ACS +0.63% 60 EBIT is €8.3 Mil as of Dec. 2025. GuruFocus rates STU:ACS with a GF Score™ of 60/100 and a GF Value™ of €1.93. The stock has 8 warning signs investors should review.

Athens Medical Centre's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €-0.1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €8.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Athens Medical Centre's annualized ROC % for the quarter that ended in Dec. 2025 was -0.77%. Athens Medical Centre's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -0.05%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Athens Medical Centre's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 2.75%.

Athens Medical Centre  (STU:ACS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Athens Medical Centre's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-3.282 * ( 1 - 1.39% )/( (412.027 + 427.853)/ 2 )
=-3.2363802/419.94
=-0.77 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=526.18 - 164.12 - ( 26.231 - max(0, 269.374 - 219.407+26.231))
=412.027

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=532.783 - 172.871 - ( 31.551 - max(0, 287.547 - 219.606+31.551))
=427.853

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Athens Medical Centre's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.144/( ( (293.901 + max(-33.687, 0)) + (299.323 + max(-29.246, 0)) )/ 2 )
=-0.144/( ( 293.901 + 299.323 )/ 2 )
=-0.144/296.612
=-0.05 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(132.7 + 7.695 + 5.807) - (164.12 + 0 + 15.769)
=-33.687

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(137.106 + 7.831 + 6.906) - (172.871 + 0 + 8.218)
=-29.246

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Athens Medical Centre's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=8.34/303.237
=2.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athens Medical Centre EBIT Related Terms

Athens Medical Centre EBIT Historical Data

* Premium members only.

The historical data trend for Athens Medical Centre's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athens Medical Centre EBIT Chart

Athens Medical Centre Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.89 18.35 23.03 15.20 8.34

Athens Medical Centre Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.99 16.58 -1.39 8.41 -0.07

STU:ACS vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Athens Medical Centre's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Athens Medical Centre EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Athens Medical Centre's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Athens Medical Centre's EV-to-EBIT falls into.


STU:ACS
60GF Score
Athens Medical Centre SA STU:ACS
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athens Medical Centre EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €8.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €8.3 Mil mean?
Athens Medical Centre (STU:ACS) has a EBIT of €8.3 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Athens Medical Centre.
Is Athens Medical Centre's EBIT too high?
Athens Medical Centre's current EBIT is €8.3 Mil. Overall, Athens Medical Centre has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's EBIT compare to HCA and THC?
Athens Medical Centre's EBIT of €8.3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Athens Medical Centre. Athens Medical Centre's current EBIT is €8.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Athens Medical Centre (STU:ACS) has a current EBIT of €8.3 Mil. The stock's GF Value™ is €1.93, compared to a current price of €1.59 — trading 17.9% below its estimated fair value. The current EBIT is €8.3 Mil. Athens Medical Centre's overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Athens Medical Centre (STU:ACS), the current EBIT is €8.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Athens Medical Centre (STU:ACS) Overvalued in 2026?

Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued. The current stock price of €1.59 is trading 17.9% below its estimated GF Value™ of €1.93.

Key valuation signals for STU:ACS:

  • EBIT: €8.3 Mil
  • GF Value™: €1.93 vs. price of €1.59 (17.9% below fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the STU:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Athens Medical Centre Business Description

Other Exchanges IATR:GreeceACS:Germany
Address 5-7 Distomou Street Maroussi, Athens, GRC, 15125
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
60GF Score

Get the complete analysis for STU:ACS

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.59
Price
€1.93
GF Value